Variability of the Hepatitis B surface protein in HBV-infected liver transplant recipients

Journal of Biomedical Science

Volumn 4, Issue 4, 1997, Pages 146-154

  Schätzl, Hermann M ^a   Sieger, Emilia ^a   Jilg, Wolfgang ^c   Nitschko, Hans ^a   Zachoval, Reinhart ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

Escape mutation; Genomic variability; Hepatitis B surface protein; Hepatitis B virus; Liver transplantation

Indexed keywords

VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; REINFECTION; TREATMENT OUTCOME; VIRUS DETECTION; VIRUS TYPING;

HEPATITIS B VIRUS;

EID: 0030876220     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/BF02255643     Document Type: Article

References (34)

1. Barnaba V, Balsano S. Immunologic and molecular basis of viral persistence. The hepatitis B virus model. J Hepatol 14:391-397;1992.
2. Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22.707 men in Taiwan. Lancet ii: 1129-1133;1981.
3. Brown JL, Carman WF, Thomas HC. The clinical significance of molecular variation within the hepatitis B virus genome. Hepatology 15: 144-148;1992.
4. Brunetto MR, Giann MM, Oliveri F, Chiaberge E, Baldi M, Alfarano A, Serra A, Saracco G, Verme G, Will H. Bonmo F: Wild-type and e antigen-minus hepatitis B viruses and course of chronic hepatitis. Proc Natl Acad Sci USA 88:4186-4190;1991.
5. Carman WF, Zanetti R, Karayiannis P, Waters J, Manzillo G, Tanzi E, Zuckerman AJ. Thomas HC. Vaccine-induced escape mutant of hepatitis B virus. Lancet 336:325-329;1990.
6. Carman WF, Thomas HC. Genetically defined variants of hepatitis B virus. Rev Med Virol 1: 29-39;1991.
7. Carman WF, Thomas HC, Domingo E. Viral genetic variation: Hepatitis B virus as a clinical example. Lancet 341:349-353;1993.
8. Chazouilleres O, Mamish D, Kim M, Carey K, Ferrell L, Roberts JP, Ascher NL, Wright TL. 'Occult' hepatitis B virus as source of infection in liver transplant recipients. Lancet 343:142-146;1994.
9. Chuang WL, Omata M, Ehata T, Yokosuka O, Ito Y, Imazeki F, Lu SN, Chang WY, Ohio M, Precore mutations and core clustering mutations in chronic hepatitis B virus infection. Gastroenterology 104:263-271;1993.
10. Domingo E, Martinez-Salas E, Sobrino F, de la Torre JC, Portela A, Ortim J, Lopez-Galindez C, Perez-Brena P, Villanueva N, Najera R. et al. The quasispecies (extremely heterogenous) nature of viral RNA genome populations: Biological relevance - A review. Gene 40:1-8; 1985.
11. Douglas DD, Rakela J, Taswell HF, Krom RA, Wiesner RH. Hepatitis B virus replication patterns after orthotopic liver transplantation: De novo versus recurrent infection. Transplant Proc 25:1755-1757;1993
12. Girones R, Miller RH. Mutation rate of the Hepadnavirus genome. Virology 170:595-597; 1989.
13. Hoofnagle JH. Chronic hepatitis B. N Engl J Med 323:337-339;1990.
14. Jilg W, Sieger E, Zachoval R. Schätzl H. Individuals with antibodies against hepatitis B core antigen as the only serological marker for hepatitis B infection: High percentage of carriers of hepatitis B and C virus. J Hepatol 23:14-20; 1995.
15. Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Med 114:629-633; 1991.
16. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 339:237-238;1989.
17. Lake JR, Wright TL. Liver transplantation for patients with hepatitis B: What have we learned from our results? Hepatology 13:796-799;1991.
18. Lauchart W, Mü R, Pichlniayr R. Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver aliografts. Transplant Proc 19:2387-2389;1987.
19. Lauder IJ, Lin HJ, Lau JYN,Siu TS, Lai CL. The variability of the hepatitis B virus genome: Statistical analysis and biological implications. Mol Biol Evol 10:457-470;1993.
20. Liang TJ, Hasegawa K, Rimon N, Wands JR, Ben Porath E. Hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N Engl J Med 324:1705-1709;1991.
21. Martell M, Esteban JI, Quer J, Genesca J, Werner A, Esteban R, Guardia J, Gomez J, Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: Quasispecies nature of HCV genome distribution. J Virol 66:3225-3229;1992.
22. McMahon G, Ehrlich PH, Moustafa ZA, McCarthy LA. Dottavio D, Tolpin MD, Nadler PI, Ostberg L. Genetic alterations in the gene encoding the major HBsAg: DNA and immunological analysis of recurrent HBsAg derived from monoclonal antibody-treated liver transplant patients. Hepatology 15:757-766;1992.
23. Norder H, Couroucé AM, Magnius LO. Molecular basis of hepatitis B virus serotype variations within the four major subtypes. J Gen Virol 73:3141-3145;1992.
24. Ono Y, Onda H, Sasada R, Igarashi K, Sugino Y, Nishioka K. The complete nucleotide sequences of the cloned hepatitis B virus DNA; Subtype adr and adw. Nucleic Acids Res 11: 1747-1757;1983.
25. Ranki M, Schätzl H, Zachoval R, Uusi Oukari M, Lehtovaara P. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Hepatology 21:1492-1499;1995.
26. Repp R, Mance A, Bertram U, Niemann H, Gerlich WH, Lampen F. Persistent hepatitis B virus replication in mononuclear blood cells as a source of reinfection of liver transplants. Transplantation 52:933-935;1991.
27. Rizzetto M, Recchia S, Salizzoni M. Liver transplantation in carriers of the HBsAg. J Hepatol 13:5-7;1991.
28. Saumel D, Muller R, Graeme A, Fassati L, Ducot B, Benhamou JP, Bismuth H. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 16: 1842-1847;1993.
29. Santantonio T, Jung MC, Miska S, Pastore G, Pape GR, Will H. Prevalence and type of pre-C mutants in anti-HBe positive carriers with chronic liver disease in a highly endemic area. Virology 183:840-844;1991.
30. Schätzl H, Sieger E, Jäger G, Nitschko H, Bader L, Ruckdeschel G. Detection by PCR of human Polyomaviruses BK and JC in immunocompromised individuals and partial sequencing of control regions. J Med Virol 42:138-145; 1994.
31. Schätzl H, DaCosta M, Taylor L, Cohen FE, Prusiner SB. Prion protein gene variation among primates. J Mol Biol 245:362-374; 1995.
32. Tiollais P, Pourcel C, Dejean A. The hepatitis B virus. Nature 317:489-495;1985.
33. Vyas GN, Rao DR, Ibrahim AB. Australia antigen (hepatitis B antigen). A conformational antigen dependent on disulfide bonds. Science 178:1300-1301;1972.
34. Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet 342:1340-1344; 1993.